Skip to main content
Caplight Logo









QuantumCell ApS

QuantumCell ApS

Private
FrederiksbergHealthcare & Life Scienceshttps://qcell.ai/

Last Round

VC Round

Jul 1, 2026

Momentum

Top 25%

of companies Caplight tracks

Company Overview

QuantumCell ApS is a biotechnology company that develops an AI-native, quantum-enabled platform for neuropsychiatry drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Quantum Computing

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

drug discoveryin silico drug discoveryvirtual cell modelingCNScentral nervous systemAI drug discoveryAI-native biotechquantum-enabled simulationcomputational biologypredictive modelingsmall-molecule therapeuticsbiotech licensingneuropsychiatric disordersdigital twinspharma R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

QuantumCell ApS Comparables

Compare QuantumCell ApS with similar companies based on industry and business-model similarity.

QuantumCell ApS comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
DeepLife
81%
Qubit Pharmaceuticals
79%
Netabolics
77%

QuantumCell ApS Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 1, 2026
SeedDec 1, 2025

QuantumCell ApS Investors

Notable investors and investment history

QuantumCell ApS investors
InvestorRounds
Lundbeck FoundationSeed
Novo HoldingsSeed
The Export and Investment Fund of DenmarkVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2026

    $18.3M round led by The Export and Investment Fund of Denmark.

  • Dec 1, 2025

    Seed round with Novo Holdings and Lundbeck Foundation.

QuantumCell ApS Filings

Explore SEC and related filing metadata, where available.

QuantumCell ApS filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about QuantumCell ApS's valuation, stock price, and market status.

Is QuantumCell ApS a public or private company?

QuantumCell ApS is a private company.

What is the current stock price of QuantumCell ApS?

QuantumCell ApS is a private company with no public stock price. Caplight tracks QuantumCell ApS's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is QuantumCell ApS worth (valuation)?

Valuation information for QuantumCell ApS is not publicly available.

Can I buy QuantumCell ApS stock?

QuantumCell ApS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was QuantumCell ApS's last funding round?

QuantumCell ApS's most recent funding round was VC Round on July 1, 2026.

Who are the main investors in QuantumCell ApS?

Key investors in QuantumCell ApS include Lundbeck Foundation, Novo Holdings, The Export and Investment Fund of Denmark.

Will QuantumCell ApS IPO soon?

No public IPO plans have been announced for QuantumCell ApS.

How can I track QuantumCell ApS secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor QuantumCell ApS's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersFrederiksberg
Year Founded2025
Last FundingJul 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?